High serum levels of IL-6 have been associated with advanced stage disease and worse prognosis for several cancer types including ovarian, breast and colorectal (Berek et al, 1991; Zhang and Adachi, 1999; Belluco et al, 2000; Bachelot et al, 2003). Here, IL6 is linked to cancer.